Financials data is unavailable for this security.
View more
Year on year Gentian Diagnostics ASA grew revenues 32.98% from 101.64m to 135.15m while net income improved from a loss of 23.62m to a smaller loss of 10.65m.
Gross margin | 51.06% |
---|---|
Net profit margin | -1.37% |
Operating margin | -2.70% |
Return on assets | -1.07% |
---|---|
Return on equity | -1.28% |
Return on investment | -1.21% |
More ▼
Cash flow in NOKView more
In 2023, Gentian Diagnostics ASA increased its cash reserves by 7.41%, or 6.04m. The company earned 15.46m from its operations for a Cash Flow Margin of 11.44%. In addition the company used 4.88m on investing activities and also paid 4.60m in financing cash flows.
Cash flow per share | 0.4678 |
---|---|
Price/Cash flow per share | 101.63 |
Book value per share | 10.20 |
---|---|
Tangible book value per share | 8.65 |
More ▼
Balance sheet in NOKView more
Current ratio | 6.73 |
---|---|
Quick ratio | 4.83 |
Total debt/total equity | 0.0494 |
---|---|
Total debt/total capital | 0.047 |
More ▼